AIPNasdaqSemiconductors & Related DevicesFiscal year ends December 31
Arteris, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$19.08+0.32 (+1.71%)
Close on Oct 19, 2026
- Market cap
- $902.04M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Gross margin
90.2%−5.1 pts over 5 years
Operating margin
-47.0%−35.1 pts over 5 years
Net margin
-49.2%−39.0 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +22.3% | +11.9% | +17.3% | – | |
| Gross profit | +23.0% | +11.4% | +16.0% | – | |
| Free cash flow | – | – | +28.8% | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 30.4% | 439.3% | |
| Return on assets | – | – | -31.4% | |
| Current ratio | – | 1.03 | 1.13 | |
| Interest coverage | – | -37.8× | -171.7× | |
| Capex to revenue | – | 2.1% | 2.0% | |
| Diluted shares | – | 18M | 42M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Arteris generated $30.76M from operations and spent $5.07M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$30.76M
Used
$5.07M
Capital expenditure$5.07M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-49.2%
×Asset turnover0.64×
×Equity multiplier-13.98×
=Return on equity, FY2025439.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -49.2% | 0.64× | -13.98× | 439.3% |
| FY2024 | -58.3% | 0.55× | 15.02× | -483.5% |
| FY2023 | -68.7% | 0.49× | 4.15× | -140.1% |
| FY2022 | -54.4% | 0.43× | 2.61× | -60.6% |
| FY2021 | -61.8% | 0.46× | 3.99× | -114.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$34.75M
- Cash generatingOperating cash flow above zero$6.73M
- Return on assets improvedROA up on the prior year-32.7% → -32.7%
- Earnings backed by cashOperating cash flow above net income$6.73M vs -$34.75M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.17 → 1.13
- No dilutionShare count did not rise39M → 42M
- Gross margin improvedGross margin up on the prior year89.67% → 90.23%
- More efficientAsset turnover rose0.56 → 0.66